Fluorescent Nanoparticles Coated with a Somatostatin Analogue Target Blood Monocyte for Efficient Leukaemia Treatment.
Ahmed A H AbdellatifRobert HennigKlaus PollingerHesham M TawfeekAbdellatif BouazzaouiAchim GoepferichPublished in: Pharmaceutical research (2020)
The formulated novel QDs-OCD can target SSTR2 overexpressed in blood cells with great potential for treating blood cancer.